VENTURELLI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 12.129
EU - Europa 6.275
AS - Asia 5.840
SA - Sud America 763
Continente sconosciuto - Info sul continente non disponibili 211
AF - Africa 126
OC - Oceania 15
Totale 25.359
Nazione #
US - Stati Uniti d'America 11.770
IT - Italia 1.978
CN - Cina 1.711
SG - Singapore 1.674
GB - Regno Unito 1.452
DE - Germania 722
VN - Vietnam 686
BR - Brasile 578
SE - Svezia 574
HK - Hong Kong 507
FR - Francia 336
KR - Corea 266
RU - Federazione Russa 261
BD - Bangladesh 245
FI - Finlandia 210
UA - Ucraina 187
CA - Canada 170
IN - India 146
PL - Polonia 110
TR - Turchia 109
ID - Indonesia 87
JP - Giappone 86
BG - Bulgaria 73
NL - Olanda 64
AR - Argentina 58
BE - Belgio 58
IQ - Iraq 56
MX - Messico 50
ES - Italia 43
ZA - Sudafrica 36
LT - Lituania 35
IE - Irlanda 33
CL - Cile 28
EC - Ecuador 28
AE - Emirati Arabi Uniti 27
HN - Honduras 27
UZ - Uzbekistan 27
PK - Pakistan 26
AT - Austria 23
CH - Svizzera 22
MY - Malesia 22
IL - Israele 21
SA - Arabia Saudita 20
IR - Iran 19
NI - Nicaragua 19
PH - Filippine 19
CR - Costa Rica 17
VE - Venezuela 16
CO - Colombia 15
GT - Guatemala 15
TW - Taiwan 15
JM - Giamaica 14
MA - Marocco 14
PR - Porto Rico 14
JO - Giordania 13
CZ - Repubblica Ceca 12
AU - Australia 11
AZ - Azerbaigian 11
DZ - Algeria 11
PE - Perù 11
PT - Portogallo 11
EG - Egitto 10
KE - Kenya 10
PY - Paraguay 10
RO - Romania 10
TN - Tunisia 10
UY - Uruguay 10
ET - Etiopia 9
BO - Bolivia 8
CW - ???statistics.table.value.countryCode.CW??? 8
TT - Trinidad e Tobago 8
AL - Albania 7
KZ - Kazakistan 7
NO - Norvegia 7
NP - Nepal 7
RS - Serbia 7
SC - Seychelles 7
TH - Thailandia 7
BY - Bielorussia 6
DO - Repubblica Dominicana 6
DK - Danimarca 5
EU - Europa 5
GR - Grecia 5
SN - Senegal 5
SV - El Salvador 5
GP - Guadalupe 4
HU - Ungheria 4
NZ - Nuova Zelanda 4
OM - Oman 4
BB - Barbados 3
BH - Bahrain 3
GA - Gabon 3
HR - Croazia 3
LV - Lettonia 3
PA - Panama 3
QA - Qatar 3
SI - Slovenia 3
TZ - Tanzania 3
BA - Bosnia-Erzegovina 2
BZ - Belize 2
Totale 25.125
Città #
Ashburn 1.427
Santa Clara 1.045
Singapore 1.019
Southend 926
Fairfield 727
San Jose 622
Hefei 605
Chandler 565
Woodbridge 501
Hong Kong 482
Council Bluffs 429
Houston 417
Seattle 334
Frankfurt am Main 331
Modena 326
Jacksonville 317
Ann Arbor 316
Nyköping 307
Wilmington 282
Cambridge 271
Dearborn 264
Beijing 254
Seoul 254
Ho Chi Minh City 229
Los Angeles 220
London 219
New York 208
Chicago 183
Hanoi 157
Helsinki 131
Milan 119
The Dalles 109
Munich 85
San Diego 85
Shanghai 82
Lauterbourg 80
Moscow 79
Princeton 79
São Paulo 71
Bologna 70
Sofia 70
Boardman 67
Dallas 65
Buffalo 64
Jakarta 62
Kraków 62
Fremont 61
Orem 60
Salt Lake City 55
Eugene 54
Izmir 50
Tokyo 48
Toronto 47
Brussels 46
Warsaw 44
Redwood City 42
Phoenix 38
Rome 38
Denver 37
Bremen 36
Guangzhou 36
Columbus 35
Parma 35
Atlanta 32
Montreal 31
Washington 31
Dublin 29
Grafing 29
Chennai 28
Turin 28
Brooklyn 27
Da Nang 27
Manchester 27
Reggio Emilia 27
Des Moines 26
Haiphong 26
Turku 26
Milwaukee 25
Tampa 25
Elk Grove Village 23
Tashkent 23
Ottawa 22
Baghdad 20
Brescia 20
Stockholm 20
Kent 19
Managua 19
Amsterdam 18
Boston 18
Nanjing 18
Belo Horizonte 17
Johannesburg 17
Naples 17
Sterling 17
Dhaka 16
Miami 16
Rio de Janeiro 16
Padova 15
Paris 15
Austin 14
Totale 16.203
Nome #
TYDOCK PHARMA s.r.l. Spin Off dell'Università di Modena e Reggio Emilia che ha come fine l'attività di ricerca e sviluppo nel settore delle biotech farmaceutiche. 704
An Improved Synthesis of CENTA, a Chromogenic Substrate for β-Lactamases 475
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 459
USO DI INIBITORI DELLA PTERIDINA REDUTTASI PER LA PREVENZIONE E/O IL TRATTAMENTO DI INFEZIONI PARASSITARIE 456
Constrained dansyl derivatives reveal bacterial specificity of highly conserved Thymidylate Synthases A 448
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 444
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase 444
New thymidylate synthase inhibitors induce apoptosis in melanoma cell lines 442
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 433
Biological evaluation of MR36, a novel non-polyglutamatable thymidylate synthase inhibitor that blocks cell cycle progression in melanoma cell lines 423
Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-beta-lactamases 413
Structure-based studies on species-specific inhibition of thymidylate synthase 406
Allosteric Inhibition of human Thymidylate Synthase. 400
Decoding the structural basis for carbapenem hydrolysis by class A β- lactamases: fishing for a pharmacophore 386
Multiligand approach to the identification of resistant strains overexpressing beta-lactamase 383
Thymidylate synthase structure, function and implication in drug discovery 369
IN SILICO/IN VITRO APPROACHES FOR THE IDENTIFICATION OF NEW CARBAPENEMASE INHIBITORS 369
Improving specificity vs bacterial thymidylate synthases through N-dansyl modulation of didansyltyrosine 368
Maxwell A: F1000Prime Recommendation of Evaluation [Neres J et al., ACS Chem Biol 2014]. In F1000Prime, 09 Jan 2015; DOI: 10.3410/f.725248139.793502885. F1000Prime.com/725248139#eval793502885 362
Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding 355
Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors 351
X-ray-crystallography deciphers the activity of broad spectrum boronic acid β-Lactamases inhibitors 351
ANTICANCER DRUGS 347
Pharmacological and toxicological evaluation of a new series of thymidylate synthase inhibitors as anticancer agents 343
QUINOXALINE DERIVATIVES AS ANTITUBERCULOSIS AGENTS 339
“A step further in the discovery of phthalein derivatives as Thymidylate Synthase inhibitors” 336
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer-US8916679 “B2 - Granted patent as second publication”. 332
Optimizing Cell Permeation of an Antibiotic Resistance Inhibitor for Improved Efficacy 332
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 329
Designing selective Cys-ligands to unpair the binding of the Human Transcription Enhancer Associated Domain 4 (hTEAD-4) with its modulators to halt cancer cell growth 327
The Inhibition of Extended Spectrum beta-Lactamases: Hits and Leads 325
Permeation through the cell membrane of a boron-based β-lactamase inhibitor. 318
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 317
A new strategy based on microwave-assisted technology for the extraction and purification of beeswax policosanols for pharmaceutical purposes and beyond 309
Optimization of N-alkylation in the Synthesis of Methotrexate and Pteridine-based Derivatives Under Microwave-Irradiation 308
Crystallographic studies of novel inhibitors of [beta]-lactamases 307
Pirrole-amidine oligopeptide–DNA interaction studies through Isothermal Titration Calorimetry 300
MALDI-TOF MS as a tool for rapid Identification of Low Protein Affinity Drug Fragments. 299
Long period fiber grating biosensor for the detection of drug resistant bacteria: The 'OPTObacteria' project 295
Exploiting Forster Resonance Energy Transfer (FRET) in the characterization of YAP:TEAD complex disruption 293
Target-based approaches for the discovery of new antimycobacterial drugs 290
Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase 289
Dal Ligand based design di inibitori della Timidilato Sintasi all'Analisi Comparativa dei Complessi Enzima-Inibitore 286
Feasibility Study on a Measurement Method and a Portable Measuring System to Estimate the Concentration of Cloxacillin and β -Lactamase in Milk 283
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer 275
Label-free fiber optic optrode for the detection of class C beta-lactamases expressed by drug resistant bacteria 273
Fragment Based Discovery of Thymidylate Synthase Dimeric Interface Inhibitors Through Mass Spectrometry. Invited lecture to the Fragment Based Lead Discovery track. 264
Naphthofuranone derivatives as specific inhibitors of thymidylate synthases 263
design, synthesis and biological evaluation of novel YAP:TEAD complex disruptors for thetreatment of colorectal cancer 262
NAPHTHOFURANONE DERIVATIVES AS SPECIFIC INHIBITORS OF THYMIDYLATE SYNTHASES 259
Development of a novel class of YAP:TEAD interface-3 molecular disruptors to treat colorectal carcinoma 257
A toolbox of biophysical and analytical assays helps to confirm the activity of novel hTS dimer disrupters (Ddis) with anticancer properties 257
Targeting Class A and C Serine β-Lactamases with a Broad-Spectrum Boronic Acid Derivative 257
Long period fiber grating working in reflection mode as valuable biosensing platform for the detection of drug resistant bacteria 253
Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis 253
Quinoxaline chemistry. Part 15. 4-[2-Quinoxalylmethylenimino]- benzoylglutamates and -benzoates, 4-[2-quinoxalylmethyl-N-methylamino]- benzoylglutamates as analogues of classical antifolate agents. Synthesis, elucidation of structures and in vitro evaluation of antifolate and anticancer activities 251
Merging disulphide bonds for drug design Interfering with a cancer key protein 242
Lead optimization of human thymidylate synthase dimer disrupters: from computational studies to evaluation of their biological profiles 240
Developing New beta-Lactamase Inhibitors Through Structure-Based Design and Pharmacokinetic Improvement 235
Current Treatments to Control African Trypanosomiasis and One Health Perspective 230
Targeting the dimer-monomer equilibrium of thymidylate synthase, to accelerate protein degradation and cancer cell growth inhibition 228
Enhanced anticancer effect of thymidylate synthase dimer disrupters by promoting intracellular accumulation 228
An innovative method for the extraction and HPLC analysis of bioactive policosanols from non-psychoactive Cannabis sativa L. 223
Nuovo trattamento assistito da microonde per la produzione di miscele arricchite in policosanoli da matrici cerose 223
Coupling a microwave-assisted process with HPLC-ELSD for the extraction, purification and analysis of bioactive policosanols from beeswax 223
Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases 218
Rapid-Throughput Technologies Applied to the Discovery of New Hits against Thymidylate synthase Enzymes 217
Structural and Thermodynamic analysis of novel inhibitors of beta-lactmases. 214
Lead-optimization process and characterization of the dissociative effect applied to new dimer disrupters of human Thymidylate Synthase 208
UHPLC-MS/MS screening of the hTEAD surface for the identification of novel allosteric inhibitors with anticancer activity 208
VIrtual screening identifies cross-class inhibitors of clinically relevant serine- and metallo-beta lactamases 203
Structural and thermodynamic combined studies for inhibitors binding to Thymidylate Synthase 200
Expression, purification, and characterization of Transcriptional Enhancer Associated Domain (hTEAD4), a promising target for anticancer agents 198
On the feasibility of a CENTA-based biosensor to measure antibiotics concentration in milk 196
Studi termodinamici e strutturali dell’interazione tra derivati densilici e Timidilato Sintasi Batteriche 195
Intersite Communication in Dimeric Enzymes Highlighted by Structural and Thermodynamic Analysis of Didansyltyrosine Binding to Thymidylate Synthases 194
Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective 190
Investigating the mechanism of action of the antiparasitic agent H80 through imaging techniques 185
High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic Agents 182
Optimization of chemical-biological tools for characterizing the activity of dissociative inhibitor of human thymidylate synthase 174
MS Proteomics And Biochemical Characterization Of Thymidylate Synthase Dimer Destabilizer E7 To Halt Colorectal Carcinoma 166
Reflection-type long period grating biosensor for detection of drug resistant bacteria: The OptoBacteria project 155
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1 155
Reflection-type long period grating biosensor for the detection of drug resistant bacteria: The Opto-bacteria Project 149
First total synthesis of the irciniasulfonic acids 147
Targeting of the Cysteines Surface domain of the Transcriptional Enhancer Associate Domain (TEAD) for anticancer drug discovery 140
IDENTIFICATION OF PYRAZOLO-PIPERIDINONE DERIVATIVES TARGETING YAP-TEAD INTERFACE 3 AS ANTICANCER AGENTS THROUGH INTEGRATED VIRTUAL SCREENING AND MASS SPECTROMETRY PROTEOMICS 115
Targeting the YAP:TEAD domain through fluorescence-anisotropy displacement assay 9
Totale 25.359
Categoria #
all - tutte 93.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.146 0 0 0 0 82 151 70 89 180 110 297 167
2022/20231.830 237 223 136 174 176 243 72 151 240 25 79 74
2023/20241.631 71 89 114 111 537 145 55 142 36 32 141 158
2024/20254.205 152 45 137 248 758 548 308 253 429 178 544 605
2025/20267.647 530 407 590 943 1.186 496 944 332 645 693 534 347
2026/20272.144 199 440 547 758 200 0 0 0 0 0 0 0
Totale 25.359